68 related articles for article (PubMed ID: 7242315)
1. [Hemodynamic changes at rest and during stress following isosorbide-5-mononitrate therapy in patients with coronary disease].
Isbary J; Doering W; Wauer B; Greding H; König E
Med Welt; 1981 Apr; 32(14A):530-4. PubMed ID: 7242315
[No Abstract] [Full Text] [Related]
2. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
Smolarz A; Seeliger S; Glocke M
Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
[No Abstract] [Full Text] [Related]
3. [Hemodynamic effect of 20 mg and 50 mg of 5-isosorbide mononitrate in acute and chronic therapy].
Jansen W; Osterspey A; Fuchs M; Tauchert M; Schell U; Weste S; Hombach V
Med Welt; 1982 Dec; 33(48):1756-62. PubMed ID: 6818416
[No Abstract] [Full Text] [Related]
4. [Hemodynamic effects of isosorbide-5-mononitrate in ischemic cardiopathy].
Russo G; Tolaro S; Monaco O; Greco G; Grassi R; Monaco A; Calvi V; Felis S; Tamburino C; Giuffrida G
Cardiologia; 1988 Mar; 33(3):291-5. PubMed ID: 3401892
[No Abstract] [Full Text] [Related]
5. [Hemodynamic effects of isosorbide-5-mononitrate at rest and during exertion in patients with serious angina pectoris].
Biamino G; Oeff M; Andresen D; Lichey HJ; Prokein E; Arntz R; von Leitner E; Schröder R
Med Welt; 1981 Apr; 32(14A):535-9. PubMed ID: 7242316
[No Abstract] [Full Text] [Related]
6. Hemodynamic effects of isosorbide-5-mononitrate in acute and chronic treatment of coronary heart disease.
Schuster P; Trieb G; Wiechmann HW
Z Kardiol; 1983; 72 Suppl 3():251-4. PubMed ID: 6666229
[TBL] [Abstract][Full Text] [Related]
7. [Effect of isosorbide-5-mononitrate (IS-5-MN) on left ventricular hemodynamics].
Mehmel HC; Ruffmann K; Schwarz F; Manthey J; Kübler W
Med Welt; 1981 Apr; 32(14A):527-9. PubMed ID: 7242314
[No Abstract] [Full Text] [Related]
8. Acute effect of various doses of isosorbide-5-mononitrate on hemodynamic and exercise performance in coronary artery disease.
Jansen W; Meyer L; Tauchert M
Am J Cardiol; 1988 Mar; 61(9):31E-35E. PubMed ID: 3348138
[TBL] [Abstract][Full Text] [Related]
9. [Isosorbide-5-mononitrate. Hemodynamic studies during subchronic therapy].
Wiechmann HW; Schuster P; Trieb G
Med Welt; 1983 Jul; 34(27):765-7. PubMed ID: 6888248
[No Abstract] [Full Text] [Related]
10. [Delayed-action isosorbide-5-mononitrate preparations--are there differences in the acute effect?].
Jansen W; Geppert R; Weidmann B; Tauchert M
Med Klin (Munich); 1987 Nov; 82(24):854-9. PubMed ID: 3431518
[No Abstract] [Full Text] [Related]
11. Hemodynamic effects of oral isosorbide-5-mononitrate and dinitrate in ischemic heart failure.
Rabinowitz B; Hod H; Chouraqui P; Rath S; Agranat O; Neufeld HN
Clin Cardiol; 1987 Oct; 10(10):603-8. PubMed ID: 3665218
[TBL] [Abstract][Full Text] [Related]
12. [Ergometric and clinical results of treating coronary disease with isosorbide dinitrate and verapamil].
Pozenel H
Med Welt; 1981 Jun; 32(24):988-92. PubMed ID: 7253907
[No Abstract] [Full Text] [Related]
13. [Steady state kinetics of isosorbide-5-mononitrate in patients with coronary disease].
Mannebach H; Ohlmeier H; von Möllendorff E; Gleichmann U; Abshagen U
Med Welt; 1981 Apr; 32(14A):517-20. PubMed ID: 7242311
[No Abstract] [Full Text] [Related]
14. [Isosorbide mononitrate or dinitrate in coronary disease?].
Schanzenbächer P; Kochsiek K
Dtsch Med Wochenschr; 1983 May; 108(21):807-9. PubMed ID: 6851870
[No Abstract] [Full Text] [Related]
15. [Comparative invasive examination of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in chronic coronary insufficiency].
Bödigheimer K; Nowak FG; Delius W
Med Welt; 1981 Apr; 32(14A):543-7. PubMed ID: 7242318
[No Abstract] [Full Text] [Related]
16. [Hemodynamic effects of isosorbide-5-mononitrate in coronary heart disease. A comparison of acute and chronic treatment].
Wiechmann HW; Schuster P; Trieb G
Dtsch Med Wochenschr; 1983 Sep; 108(35):1304-7. PubMed ID: 6884214
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effectiveness of isosorbide-5-mono nitrate in the treatment of exertion myocardial ischemia].
Cassottana P; Torre F; Bafico GL; Oddone D; Vinci P; Gatto R; Borgo E
Minerva Cardioangiol; 1987; 35(1-2):79-82. PubMed ID: 3561813
[No Abstract] [Full Text] [Related]
18. [Hemodynamic effect, effect duration and pharmacokinetics of 80 mg of isosorbide-5-mononitrate in acute myocardial infarct].
Reifart N; Bussmann WD; Schirmer M; Kaltenbach M
Med Welt; 1981 Apr; 32(14A):540-2. PubMed ID: 7242317
[No Abstract] [Full Text] [Related]
19. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
Reifart N; Reifart F; Kaltenbach M; Bussmann WD
Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
[No Abstract] [Full Text] [Related]
20. Efficacy of isosorbide-5-mononitrate in the prevention of myocardial ischemia induced by ergonovine and by hand-grip tests.
Distante A; Lombardi M; Moscarelli E; Morales MA; Sabino F; L'Abbate A
Z Kardiol; 1985; 74 Suppl 4():25-31. PubMed ID: 4096068
[No Abstract] [Full Text] [Related]
[Next] [New Search]
